Follow up of Intravesical N-803 Plus BCG in BCG-Naive Non-Muscle Invasive Bladder Cancer (NMIBC)

Running, not enrolling

Conditions studied: Non Muscle Invasive Bladder Cancer

In brief

The purpose of this clinical trial is to obtain long-term follow-up information and status of bladder cancer for patients who received study treatment in the QUILT-2.005 study.

Key facts

Study ID

NCT05981131

Run by

ImmunityBio, Inc.

People needed

6

Starts

2023-08-17

Expected to finish

2033-08-30

Last updated by the study team

2026-04-29

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Enrolled and treated with intravesical N-803 plus BCG in the phase 1b portion of QUILT-2.005.

You may not qualify if…

• Not applicable

Where it is running

• Island Urology — Honolulu, Hawaii, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.